SBH

Sangui Biotech International, Inc. Stock Price

HMSE:SBH Community·€419.8k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

SBH Share Price Performance

€0
0.00 (0.00%)
€0
0.00 (0.00%)
Price €0

SBH Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Fair value with imperfect balance sheet.

4 Risks
2 Rewards

Sangui Biotech International, Inc. Key Details

US$117.4k

Revenue

US$0

Cost of Revenue

US$117.4k

Gross Profit

US$160.8k

Other Expenses

-US$43.3k

Earnings

Last Reported Earnings
Mar 31, 2024
Next Reporting Earnings
n/a
-0.00021
100.00%
-36.89%
-72.3%
View Full Analysis

About SBH

Founded
1995
Employees
n/a
CEO
Thomas Striepe
WebsiteView website
www.sanguibiotech.com

Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. The company offers artificial oxygen carriers comprising oxygen carrying blood additives and oxygen carrying blood volume substitutes; nano formulations for the regeneration of skin; chitoskin wound pads; Hemospray, a hemoglobin based wound spray; and wound dressing spray under the Granulox brand. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.

Recent SBH News & Updates

Recent updates

No updates